Skip to main content

Smoking Causes Diabetes

Active smokers have a 30% to 40% higher risk of developing type 2 diabetes compared with nonsmokers, according to new data published in the Surgeon General's 50-year anniversary report on smoking.
The Health Consequences of Smoking — 50 Years of Progress , announced at the White House last Friday by current acting Surgeon General Boris Lushniak, MD, MPH, highlights diabetes as one of several new diseases causally linked to smoking.

Newer studies have controlled for those and other co founders and have also demonstrated a dose-response relationship, as well as a reduction in diabetes risk following smoking cessation.

So now, the Surgeon General report concludes: "The evidence is sufficient to infer that cigarette smoking is a cause of diabetes."

"The link between smoking and diabetes is really interesting," Serena Tonstad, MD, PhD, MPH, professor at the School of Public Health, Loma Linda University, California, told Medscape Medical News.


Epidemiologic and Biological Evidence

The new report includes a meta-analysis, which updates a 2007 systemic review by adding a further 24 studies. All were prospective cohort studies, and none included individuals who already had diabetes at baseline. In all, the meta-analysis included over 3.9 million subjects, of whom 140,813 subsequently developed diabetes.

The various studies adjusted for many potential confounders, including age, body mass index, physical activity, diet, alcohol consumption, family history of diabetes, gender, race/ethnicity, and educational level.
Compared with nonsmokers, the smokers had a pooled risk ratio for developing type 2 diabetes of 1.37.

Stronger associations were seen in studies that used blood glucose measures to assess the presence of diabetes, rather than in those that relied on patient or physician reports.

A dose-response analysis provides further proof of direct causation. Compared with never-smokers, the relative risk for developing diabetes increased with smoking intensity from 1.14 for former smokers to 1.25 for light smokers (0 – 19 or 0 – 15 cigarettes/day in the various studies) to 1.54 for heavy smokers ( > 15 or > 20), all statistically significant. 

A third line of evidence for causation comes from 4 studies on smoking cessation. One review found improved insulin sensitivity among individuals who quit smoking, despite weight gain.

Another large study found that the risk of incident type 2 diabetes among those who quit smoking actually increased in the short term but fell to that of never-smokers by 12 years after cessation, while another found that the risk fell to that of never-smokers after 5 years for women and 10 years for men.
Due to "limited evidence," however, the report does not discuss the effects of passive smoking on diabe­tes or the adverse effects of smoking on the development of diabetic complications.

But the new Surgeon General's report does provide several possible biologic mechanisms for the causal connection between smoking cigarettes and the development of type 2 diabetes.

For one, smoking promotes central obesity, a well-established risk factor for insulin resistance and diabetes. This effect may be related to higher cortisol concentrations and the differential effect of smoking on sex hormones, the data indicate.

Smoking also increases inflammatory markers and oxidative stress, both implicated in the development of insulin resistance and abnormal glucose metabolism.
And both human and animal studies have found functional nicotinic receptors on pancreatic islet and beta cells. Nicotine could, at least in part, reduce the release of insulin via islet-cell receptors. Animal studies also suggest that prenatal or neonatal exposure to nicotine can cause beta-cell dysfunction and apoptosis, according to the report. Source:
medscape.com
The Health Consequences of Smoking — 50 Years of Progress. published online January 17, 2014.
Report

Comments

Popular posts from this blog

Final lunar eclipse of 2010 set for early morning of December 21

Skygazers hoping to catch the last lunar eclipse of 2010 on Tuesday morning best be ready to stay up late (or wake up very early) to watch the full moon as it goes through a range of dramatic color changes. The December 21 lunar eclipse is expected to last about three-and-a-half hours from its start as a partial eclipse at 1:33 a.m. ET to its finish at 5:01 a.m. ET, according to NASA. The previous lunar eclipse occurred June 26 . During a lunar eclipse, the moon, the Earth, and the sun align so that the sun's rays are shielded from the moon. An eclipse of the moon can only take place if the moon is full, and only if the moon passes through some portion of Earth's shadow, which is composed of two cone-shaped parts, one nested inside the other. The start of the total eclipse is expected around 2:41 a.m, when the entire moon passes through the Earth's umbra, or inner shadow, which blocks all direct sunlight from reaching the moon. The moon will tak...

Men With Breast Cancer Face Worse Prognosis

Men who are diagnosed with breast cancer are more likely than female patients to die in the next 15 years, researchers report. "This may be due to a difference in tumor characteristics and treatment," says study leader Hui Miao, a PhD candidate at the National University of Singapore. Male breast cancer is rare, accounting for less than 1% of all breast cancers in the U.S. Given its scarcity, few studies have assessed its prognosis "and we know of no recent studies looking at trends in survival," Miao tells WebMD. So Miao and colleagues studied 459,846 women and 2,664 men diagnosed with breast cancer in Denmark, Finland, Switzerland, Norway, Singapore, and Sweden between 1970 and 2007. Among the findings, presented at the San Antonio Breast Cancer Symposium: Men were diagnosed at an older age: 69 vs. 61 for women. Twice as many men had later stage III or IV disease: 18% vs. 9% of women. Only 25% of men were alive 15 years after diagnosis, compared with 44...

Permitted non-hormonal performance-enhancing substances

What? Performance enhancers? For decades athletes and non-athletes have been using performance-enhancing drugs/supplements> However most of the time the news  flash comes when a competitive athlete is caught using banned hormonal & non-hormonal substances. They can be broadly classified as: Stimulants Prescription medications Blood buffers Nutritional supplements Energy beverages STIMULANTS They are both physical and cognitive performance enhancers.  Beneficial effects include increase in: Energy level,  Endurance,  Anaerobic performance, r Reaction time,  Concentration, and alertness.  Adverse effects include Headache,  Nausea,  Insomnia,  Anxiety,  Tremor,  Agitation,  Panic attacks,  Hypertension, and tachycardia.  Rarely, stimulants may cause myocardial ischemia, stroke, psychosis, heatstroke, or rhabdomyolysis. While many stimulants (eg, methylhexana...